KLF4 and atherosclerosis: Because TMAO, a gut-microbiota-dependent metabolite, has been shown to enhance atherosclerosis in animal models and is associated with cardiovascular risks in clinical studies25, we sought to investigate the relationship between TMAO-induced atherosclerosis and KLF4-induced glycolytic switch in VSMCs.